Urinary polycyclic aromatic hydrocarbon biomarkers and diabetes mellitus

Occupational and Environmental Medicine

Volumn 71, Issue 6, 2014, Pages 437-441

  Alshaarawy, Omayma ^a   Zhu, Motao ^b   Ducatman, Alan M ^b   Conway, Baqiyyah ^b   Andrew, Michael E ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; ORAL ANTIDIABETIC AGENT; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OBESITY; PRIORITY JOURNAL; SELF CONCEPT;

ANIMALIA;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; POLYCYCLIC HYDROCARBONS, AROMATIC; UNITED STATES; YOUNG ADULT;

EID: 84900824663     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oemed-2013-101987     Document Type: Article

References (32)

1. Parker VG, Mayo RM, Logan BN, et al. Toxins and diabetes mellitus: an environmental connection? Diabetes Spectrum 2002;15:109-12.
2. Taylor KW, Novak RF, Anderson HA, et al. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect 2013;121:774-83.
3. Warshawsky D. Polycyclic aromatic hydrocarbons in carcinogenesis. Environ Health Perspect 1999;107:317-19.
4. Talaska G, Underwood P, Maier A, et al. Polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs and related environmental compounds: biological markers of exposure and effects. Environ Health Perspect 1996;104:901-6. (Pubitemid 26402328)
5. Angerer J, Mannschreck C, Gundel J. Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons. Int Arch Occup Environ Health 1997;70:365-77. (Pubitemid 27514244)
6. Ramesh A, Walker SA, Hood DB, et al. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 2004;23:301-33. (Pubitemid 39451824)
7. Simko P. Factors affecting elimination of polycyclic aromatic hydrocarbons from smoked meat foods and liquid smoke flavorings. Mol Nutr Food Res 2005;49:637-47. (Pubitemid 41014822)
8. St Helen G, Goniewicz ML, Dempsey D, et al. Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol 2012;25:952-64.
9. Li Z, Romanoff L, Bartell S, et al. Excretion pro files and half-lives of ten urinary polycyclic aromatic hydrocarbon metabolites after dietary exposure. Chem Res Toxicol 2012;25:1452-61.
10. Khalil A, Villard PH, Dao MA, et al. Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett 2010;196:161-7.
11. Wang SL, Tsai PC, Yang CY, et al . Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 2008;31:1574-9.
12. Elovaara E, Heikkila P, Pyy L, et al. Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene. Occup Environ Med 1995;52:196-203.
13. McClean MD, Osborn LV, Snawder JE, et al. Using urinary biomarkers of polycyclic aromatic compound exposure to guide exposure-reduction strategies among asphalt paving workers. Ann Occup Hyg 2012;56:1013-24.
14. Olatubi OA. Metabolism of mixtures of polycyclic aromatic hydrocarbons (PAHs) by Cunninghamella elegans. Master's thesis, Texas A&M University. Texas A&M University. Available electronically from http://hdl. handle. net/1969 2005;1:4944.
15. Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010.
16. American Diabetes Association. Standards of Medical Care in Diabetes - 2010. Diabetes Care 2010;33:S11-61.
17. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Laboratory Protocol. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, MD: US, 2006.
18. Barr DB, Wilder LC, Caudill SP, et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200. (Pubitemid 40326330)
19. Castano-Vinyals G, D'Errico A, Malats N, et al. Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution. Occup Environ Med 2004;61:e12.
20. Jeng HA, Pan CH, Diawara N, et al. Polycyclic aromatic hydrocarbon-induced oxidative stress and lipid peroxidation in relation to immunological alteration. Occup Environ Med 2011;68:653-8.
21. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17:24-38. (Pubitemid 36410972)
22. Curfs DM, Knaapen AM, Pachen DM, et al. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J 2005;19:1290-2. (Pubitemid 41113726)
23. Alshaarawy O, Zhu M, Ducatman A, et al. Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men. Environ Res 2013;126:98-104.
24. Everett CJ, King DE, Player MS, et al. Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environ Res 2010;110:79-82.
25. Calle MC, Fernandez ML. In flammation and type 2 diabetes. Diabetes Metab 2012;38:183-91.
26. Archibong AE, Inyang F, Ramesh A, et al. Alteration of pregnancy related hormones and fetal survival in F-344 rats exposed by inhalation to benzo(a)pyrene. Reprod Toxicol 2002;16:801-8. (Pubitemid 35278502)
27. Zhang Y, Howard BV, Cowan LD, et al. The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women: the strong heart study. Diabetes Care 2002;25:500-4. (Pubitemid 41103343)
28. Barros RP, Machado UF, Gustafsson JA. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 2006;12:425-31. (Pubitemid 44308462)
29. Connor Gorber S, Schofield-Hurwitz S, Hardt J, et al. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009;11:12-24.
30. Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report? Prev Med 1995;24:171-9.
31. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107(Suppl 2):349-55. (Pubitemid 29264045)
32. Copeland KT, Checkoway H, McMicheal AJ, et al. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105:488-95. (Pubitemid 8112070)